FindTrial
Sign In

Impact of COVID-19 pandemic on cancer diagnosis, treatment, and death in Japan: national-level registration study.

Impact of COVID-19 pandemic on cancer diagnosis, treatment, and death in Japan: national-level registration study. - Impact of COVID-19 pandemic on cancer diagnosis, treatment, and death in Japan: national-level registration study.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000046307
Enrollment
Unknown
Registered
2021-12-07
Start date
2021-12-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Sponsors

Yokohama City University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were given the diagnosis of cancers, treated for cancers, and died from cancers.

Exclusion criteria

Exclusion criteria: Not set.

Design outcomes

Primary

MeasureTime frame
How the COVID-19 pandemic has affected the number of diagnoses, treatments, and deaths of various cancers in 2020 and 2021 in terms of percentage decrease/increase from estimation from previous years—

Countries

Japan

Contacts

Public ContactNobuyuki Horita

Yokohama City University Hospital Chemotherapy Center

horitano@yokohama-cu.ac.jp0457872800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026